DI FRANCESCO, JACOPO COSIMO
 Distribuzione geografica
Continente #
NA - Nord America 7.229
EU - Europa 3.479
AS - Asia 3.262
SA - Sud America 562
AF - Africa 62
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
Totale 14.609
Nazione #
US - Stati Uniti d'America 7.065
SG - Singapore 1.297
CN - Cina 827
DE - Germania 724
IT - Italia 655
RU - Federazione Russa 523
HK - Hong Kong 494
BR - Brasile 463
SE - Svezia 393
IE - Irlanda 283
VN - Vietnam 236
GB - Regno Unito 224
FI - Finlandia 176
UA - Ucraina 168
CA - Canada 120
IN - India 92
FR - Francia 80
AT - Austria 52
TR - Turchia 47
JP - Giappone 44
AR - Argentina 40
ID - Indonesia 36
ZA - Sudafrica 36
KR - Corea 32
PL - Polonia 32
BE - Belgio 31
DK - Danimarca 30
BD - Bangladesh 28
ES - Italia 27
MX - Messico 25
NL - Olanda 25
IQ - Iraq 23
EC - Ecuador 18
CL - Cile 14
UZ - Uzbekistan 14
PK - Pakistan 13
IR - Iran 12
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
VE - Venezuela 9
SA - Arabia Saudita 8
EU - Europa 7
LT - Lituania 7
PH - Filippine 7
PY - Paraguay 7
DO - Repubblica Dominicana 6
MA - Marocco 6
GE - Georgia 5
PT - Portogallo 5
AL - Albania 4
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
IL - Israele 4
RO - Romania 4
AU - Australia 3
BH - Bahrain 3
BO - Bolivia 3
CO - Colombia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
HU - Ungheria 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
MY - Malesia 3
NG - Nigeria 3
NI - Nicaragua 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
CR - Costa Rica 2
DZ - Algeria 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
JM - Giamaica 2
KW - Kuwait 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
MU - Mauritius 2
NO - Norvegia 2
NP - Nepal 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AO - Angola 1
BS - Bahamas 1
BY - Bielorussia 1
GD - Grenada 1
HN - Honduras 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
Totale 14.603
Città #
Ann Arbor 1.487
Singapore 835
Ashburn 650
Hong Kong 490
Chandler 410
Fairfield 392
Woodbridge 392
Frankfurt am Main 373
Wilmington 340
Dublin 274
Houston 264
Milan 227
New York 204
Santa Clara 195
San Jose 178
Jacksonville 176
Munich 174
Beijing 161
Dearborn 160
Seattle 154
Los Angeles 151
Cambridge 132
Princeton 114
Helsinki 112
Dallas 98
Nanjing 80
Shanghai 67
The Dalles 65
São Paulo 64
Ho Chi Minh City 58
Hefei 54
Buffalo 53
Moscow 53
Lawrence 47
Hanoi 45
Chicago 43
Altamura 38
Dong Ket 37
Vienna 35
Jakarta 30
Lachine 30
Council Bluffs 29
Seoul 28
Tokyo 27
Boardman 26
Brooklyn 26
Guangzhou 26
Nuremberg 25
Orem 25
Brussels 24
Denver 24
Warsaw 23
Andover 22
Jinan 22
London 22
Montreal 22
Ottawa 22
Grafing 21
Monza 21
Boston 20
Johannesburg 20
San Diego 20
Nanchang 19
Pune 19
Toronto 19
Fremont 18
Rome 17
Stockholm 17
Changsha 16
Zhengzhou 16
Shenyang 15
Tianjin 15
Ankara 14
Kocaeli 14
Phoenix 14
Poplar 14
Tashkent 14
Atlanta 13
Columbus 13
Rio de Janeiro 13
Santiago 13
Turku 13
Chennai 12
Falls Church 12
Manchester 12
Salt Lake City 12
Hebei 11
Curitiba 10
Hangzhou 10
Lissone 10
Mexico City 10
Edmonton 9
Jyväskylä 9
Leawood 9
Monmouth Junction 9
San Francisco 9
Guayaquil 8
Haiphong 8
Jiaxing 8
Mountain View 8
Totale 9.919
Nome #
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies 462
Cardiac and neuronal HCN channelopathies 453
TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy 419
Effect of the ketogenic diet in excitable tissues 385
Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): Candidate biomarker for immunotherapy in Alzheimer's disease and cerebral amyloid angiopathy 375
Clinical, biological and neuroradiological evolution of Cerebral Amyloid Angiopathy-related inflammation: the iCAβ International Network longitudinal study. 372
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 368
Progressive epileptic encephalopathy associated with a novel HCN2 mutation 330
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 329
Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease 326
Generation and validation of algorithms to identify subjects with dementia using administrative data 321
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 299
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 297
Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study 288
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics 288
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 284
Do the functional properties of HCN1 mutants correlate with the clinical features in epileptic patients? 284
Cerebellar hematoma in a carrier of the A3243G MELAS mutation 264
Prodromal Alzheimer's Disease Presenting as Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Amyloid-Related Imaging Abnormalities and High Cerebrospinal Fluid Anti-Aβ Autoantibodies 264
Novel neurofibromatosis type 2 mutation presenting with status epilepticus 263
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-A beta auto-antibodies 259
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 251
Brain targets: can you believe your own eyes? 245
Cerebral Amyloid Angiopathy-Related Inflammation 245
Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation 239
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome 235
HCN1 novel mutations in familiar generalized epilepsy 232
A case of Leber hereditary optic neuropathy plus dystonia caused by G14459A mitochondrial mutation 228
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study 223
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report 222
Huntington's disease and HDACi: Would sulpiride and valproate be of therapeutic value? 218
HCN1 mutation spectrum: From neonatal epileptic encephalopathy to benign generalized epilepsy and beyond 214
Long-term risk of chronic epilepsy in adults after post-anoxic coma and refractory status epilepticus: A retrospective cohort study 214
Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 213
COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease 211
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 209
MELAS mitochondrial DNA mutation A3243G reduces glutamate transport in cybrids cell lines 205
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet 204
Cerebral amyloid angiopathy-related inflammation: an emerging disease 202
Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel variants and associated phenotypes 201
Autoimmune encephalopathy in Graves' disease: Remission after total thyroidectomy 199
Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review 198
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 196
Neurological soft signs are increased in migraine without aura: relationship with the affective status 195
Epilptic seizures and psychogenic non-epileptic seizures 194
Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAβ International Network 194
Discovering the Italian phenotype of cerebral amyloid angiopathy (CAA): the SENECA project 193
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 192
Adult-Onset Epilepsy in Presymptomatic Alzheimer's Disease: A Retrospective Study 189
Epilepsy in Cerebral Amyloid Angiopathy: an observational retrospective study of a large population 184
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 183
Anti-Aß autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 179
Association of Microglial Activation With Spontaneous ARIA-E and Cerebrospinal Fluid Levels of Anti-Aβ Autoantibodies 178
A loss-of-function HCN4 mutation associated with familial benign myoclonic epilepsy in infancy causes increased neuronal excitability 171
Complicanze neurologiche di malattie internistiche 164
Recessive loss-of-function mutation in the pacemaker HCN2 channel causing increased neuronal excitability in a patient with idiopathic generalized epilepsy 161
Cerebral Amyloid Angiopathy-Related Inflammation: Report of a Case with Very Difficult Therapeutic Management 158
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-Aβ auto-antibodie 158
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 154
The management of epilepsy in clinical practice: Do the timing and severity of the disease influence the priorities of patients and the caring physicians? Data from the EPINEEDS study 150
Anti-AB autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's disease Biomarkers Collaborative Network 145
Clinical and Instrumental Characterization of Patients With Late-Onset Epilepsy 141
LATE-ONSET EPILEPSY WITH UNKNOWN ETIOLOGY: A PILOT STUDY ON NEUROPSYCHOLOGICAL PROFILE, CEREBROSPINAL FLUID BIOMARKERS, AND QUANTITATIVE EEG CHARACTERISTICS 139
Totale 15.156
Categoria #
all - tutte 48.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021877 0 0 0 0 0 0 147 174 147 151 109 149
2021/20221.015 119 111 115 84 84 94 34 46 50 48 78 152
2022/20231.695 162 472 158 188 124 237 34 82 167 11 25 35
2023/20241.056 27 62 49 69 152 257 162 56 78 11 17 116
2024/20252.687 135 283 156 97 216 180 250 153 280 388 211 338
2025/20263.874 722 295 481 837 843 312 384 0 0 0 0 0
Totale 15.156